Rabinowitz Matthew sold $21.4M of NTRA
Rabinowitz Matthew (EXECUTIVE CHAIRMAN) sold 100,000 shares of Natera, Inc. (NTRA) at an average of $214.47 ($209.50–$219.36, $21.45M total) across 21 trades over 2026-06-12 to 2026-06-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete, time-stamped insider selling event (open-market sale) with a disclosed weighted-average price range and post-transaction holdings, which can influence short-term sentiment and positioning.
Market read
A large insider sale (~$21.45M) was reported, but the presence of a 10b5-1 plan suggests reduced informational content versus unscheduled selling.
What to watch
Traders may over-weight the headline size; the key is whether there are additional insider sales around the same window or any concurrent fundamental disclosures not included here.
Background
The article summarizes an SEC Form 4 insider transaction for Natera, Inc. (NTRA) by executive chairman Matthew Rabinowitz.
Ticker impact
Natera executive chairman Matthew Rabinowitz sold about 100,000 shares in open-market trades for ~$21.45M under a 10b5-1 plan.
Likely limited, short-lived negative bias unless follow-on selling or other fundamentals emerge.
The filing is a primary-source Form 4 showing a large sale, yet it is explicitly pre-arranged under Rule 10b5-1, which typically dampens interpretation of insider conviction.
Market effects
No direct sector read-through; this is company-specific insider liquidity/positioning rather than a sector catalyst.
Minimal; US-listed single-name insider transaction.
Low; no cross-border deal/regulatory element described.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled diversification/liquidity needs rather than bearish expectations.
Key entities
- issuerNatera, Inc.
US-listed company whose executive chairman sold shares via open-market transactions under a 10b5-1 plan.
- insiderMatthew Rabinowitz
Executive Chairman and director who executed the reported sales.
